Godsey & Gibb Inc’s Avanos Medical AVNS Stock Holding History

Godsey & Gibb Inc’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-37	Closed	-$737	–	404
2024 Q1	$737	Buy	+37	New	+$715	﹤0.01%	362

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Godsey & Gibb Inc's AVNS Position: Q2 2024 in Review

Godsey & Gibb Inc sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 37 shares — an estimated $737 sold.

Godsey & Gibb Inc first reported a position in AVNS in Q1 2024 and held it in 1 quarter. The position peaked at $737 in Q1 2024. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

Godsey & Gibb Inc reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
Godsey & Gibb Inc sold 37 Avanos Medical shares in Q2 2024, an estimated $737.
Godsey & Gibb Inc first reported a position in Avanos Medical in Q1 2024 and held it in 1 quarter.
Godsey & Gibb Inc's Avanos Medical position peaked at $737 in Q1 2024.
258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Godsey & Gibb Inc's 13F filing for Q2 2024, filed 23 Jul 2024.